The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List
ChartZero.com

PARTNER NEWS:

Tue, Apr 15, 3:25 PM, Zacks
Eli Lilly/ Boehringer Drug Under FDA Review - Analyst Blog
Eli Lilly/ Boehringer new drug application (NDA) for their empagliflozin/Tradjenta (linagliptin) combination has been accepted for review by the FDA for type II diabetes.

Tue, Apr 15, 3:11 PM, Zacks
FDA Nod for Merck's Grastek - Analyst Blog
Merck announced that the FDA has approved Grastek, a timothy grass pollen allergen extract.

Merck & Co., Inc (MRK)

Merck & Co. is a health care company that provides prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. Co.'s operations are comprised of four operating segments: pharmaceutical, which include therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders; animal health, which develops, manufactures and markets animal health products, including vaccines; consumer care, which develops, manufactures and markets over-the-counter, foot care and sun care products; and alliances, which includes Co.'s relationship with AstraZeneca LP.

Company Name:  Merck & Co., Inc
Website:  www.merck.com
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding MRK:  96
Total Market Value Held by ETFs:  $10.41B
Total Market Capitalization:  $164.82B
% of Market Cap. Held by ETFs:  6.31%

April 17, 2014    8:24 PM Eastern


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quotes delayed 20 minutes

Trade MRK Now:



Buy (3.04 out of 4)
54th percentile
(ranked higher than approx. 54% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Merck & Co., Inc (MRK) Page | The Online Investor | www.TheOnlineInvestor.com | Copyright © 1998 - 2014, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.